Form 4: Jennifer Doudna Receives Stock Grant at Tempus AI

Director Jennifer A. Doudna was awarded 5,913 restricted stock units as part of her compensation, increasing her total holdings in the company.

Summary

• Jennifer A. Doudna, a member of the Board of Directors, acquired 5,913 shares of Class A Common Stock on May 21, 2026.
• The acquisition was in the form of Restricted Stock Units (RSUs) granted at a price of $0.00 as part of director compensation.
• Following this transaction, Doudna directly owns a total of 28,615 shares of Tempus AI, Inc.
• The RSUs are scheduled to vest in full on the earlier of the 2027 annual stockholders' meeting or May 21, 2027.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive administrative event, confirming the continued commitment of a key scientific advisor and director to the company's long-term mission.

Positives

• Increased insider ownership by a high-profile director and Nobel laureate.
• Alignment of director interests with long-term shareholder value through equity-based compensation.
• The grant is subject to a one-year vesting period, encouraging director retention.

Negatives

• The issuance of new shares represents a minor dilutive event for existing shareholders upon vesting.

Risks

• Vesting is contingent upon continuous service, meaning the equity may not be realized if the director leaves the board prematurely.
• The ultimate value of the compensation is subject to the market volatility of Class A Common Stock.

Future Outlook

The reporting person is expected to remain in service through at least May 2027 to satisfy the vesting conditions of the equity grant.

Management Comments

• The RSUs will vest in full on the earlier of the date of the Issuer's 2027 annual meeting of the stockholders or on May 21, 2027.

Industry Context

StockSavvy.ai notes that equity-heavy compensation for directors is a standard practice among high-growth AI and biotechnology firms to preserve cash while ensuring board members are incentivized to drive share price appreciation.

Comparison to Industry Standards

• The grant size is consistent with director compensation packages at peer technology and precision medicine companies such as Guardant Health and Illumina.
• A one-year cliff vesting schedule for director RSUs is a standard corporate governance practice in the U.S. equity markets.

Corporate Governance

Related Party Transactions

• The grant of equity to a director is a related party transaction conducted under the company's established incentive compensation plan.

Stakeholder Impact

• Shareholders: Minor dilution upon vesting, but benefit from director alignment.
• Management: Retains a high-profile expert on the board.

Next Steps

• Vesting of the 5,913 RSUs on or around May 21, 2027.
• Potential filing of a Form 4 upon the conversion of RSUs to common stock or any subsequent sale.

Key Dates

Recommendation

This is a routine compensation-related filing that does not change the fundamental valuation of the company, though it confirms the stability of the board of directors.

Keywords

Tempus AI, TEM, Jennifer Doudna, Insider Trading, Restricted Stock Units, Director Compensation, SEC Form 4, Equity Grant